1. Home
  2. AYTU vs SRFM Comparison

AYTU vs SRFM Comparison

Compare AYTU & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • SRFM
  • Stock Information
  • Founded
  • AYTU N/A
  • SRFM 2011
  • Country
  • AYTU United States
  • SRFM United States
  • Employees
  • AYTU N/A
  • SRFM N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • SRFM Transportation Services
  • Sector
  • AYTU Health Care
  • SRFM Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • SRFM Nasdaq
  • Market Cap
  • AYTU 18.8M
  • SRFM 191.9M
  • IPO Year
  • AYTU N/A
  • SRFM 2023
  • Fundamental
  • Price
  • AYTU $2.37
  • SRFM $5.10
  • Analyst Decision
  • AYTU Strong Buy
  • SRFM Buy
  • Analyst Count
  • AYTU 3
  • SRFM 4
  • Target Price
  • AYTU $9.17
  • SRFM $5.75
  • AVG Volume (30 Days)
  • AYTU 414.7K
  • SRFM 3.2M
  • Earning Date
  • AYTU 11-12-2025
  • SRFM 11-13-2025
  • Dividend Yield
  • AYTU N/A
  • SRFM N/A
  • EPS Growth
  • AYTU N/A
  • SRFM N/A
  • EPS
  • AYTU N/A
  • SRFM N/A
  • Revenue
  • AYTU $66,382,000.00
  • SRFM $107,372,000.00
  • Revenue This Year
  • AYTU N/A
  • SRFM N/A
  • Revenue Next Year
  • AYTU $19.03
  • SRFM $18.06
  • P/E Ratio
  • AYTU N/A
  • SRFM N/A
  • Revenue Growth
  • AYTU 1.84
  • SRFM N/A
  • 52 Week Low
  • AYTU $0.95
  • SRFM $1.50
  • 52 Week High
  • AYTU $2.82
  • SRFM $9.91
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 55.99
  • SRFM 58.03
  • Support Level
  • AYTU $1.65
  • SRFM $4.82
  • Resistance Level
  • AYTU $2.58
  • SRFM $6.17
  • Average True Range (ATR)
  • AYTU 0.17
  • SRFM 0.44
  • MACD
  • AYTU 0.05
  • SRFM 0.07
  • Stochastic Oscillator
  • AYTU 76.88
  • SRFM 47.39

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

Share on Social Networks: